RMI News2021-03-22T10:32:45-05:00

Signature Cord Prime™ Receives Investigational New Drug (IND) Approval from FDA for Phase 1 Study in Patients with Symptomatic Osteoarthritis of the Knee

Dallas, Texas., Feb. 16, 2021 /PRNewswire/-– Signature Biologics, LLC., a regenerative medicine company focused on the development, manufacture, and commercialization of cellular and tissue based products (HCT/P’s) for unmet human [...]

Are you a candidate? Contact us today to find out.

In-person and online evaluations are available.

APPLY

Are you a candidate? Contact us today to find out.

In-person and online evaluations are available.

APPLY

READ DR RIORDAN’S BOOK

Want to learn more about how stem cell therapy is disrupting medicine and transforming lives?

Purchase a copy of Dr. Riordan’s Amazon #1 bestselling book about stem cell therapy today!

Purchase
Go to Top